Microfluidic systems for modeling digestive cancer: a review of recent progress DOI

ZahraSadat Razavi,

M. Soltani, Hamidreza Pazoki–Toroudi

и другие.

Biomedical Physics & Engineering Express, Год журнала: 2024, Номер 10(5), С. 052002 - 052002

Опубликована: Авг. 14, 2024

Abstract Purpose . This review aims to highlight current improvements in microfluidic devices designed for digestive cancer simulation. The emphasizes the use of multicellular 3D tissue engineering models understand complicated biology tumor microenvironment (TME) and progression. purpose is develop oncology research improve patients’ lives. Methods analyzes recent on mimicking cancer. It uses tissue-engineered devices, notably organs a chip (OOC), simulate human organ function lab. Cell cultivation modern three-dimensional hydrogel platforms allows precise geometry, biological components, physiological qualities. novel methodologies, key findings, technical progress explain this field’s advances. Results study discusses advances Micro systems with are emphasized. These capture complex biochemical gradients, niche variables, dynamic cell–cell interactions (TME). reveal stomach progression by duplicating TME. Recent discoveries technology have improved our understanding gut biology, as shown review. Conclusion Microfluidic play crucial role modeling furthering research. could transform drug development treatment revealing provides complete summary suggests future field professionals. review’s major goal further medical

Язык: Английский

Organoids DOI Creative Commons
Zixuan Zhao, Xinyi Chen, Anna M. Dowbaj

и другие.

Nature Reviews Methods Primers, Год журнала: 2022, Номер 2(1)

Опубликована: Дек. 1, 2022

Organoids have attracted increasing attention because they are simple tissue-engineered cell-based in vitro models that recapitulate many aspects of the complex structure and function corresponding vivo tissue. They can be dissected interrogated for fundamental mechanistic studies on development, regeneration, repair human tissues. also used diagnostics, disease modeling, drug discovery, personalized medicine. derived from either pluripotent or tissue-resident stem (embryonic adult) progenitor differentiated cells healthy diseased tissues, such as tumors. To date, numerous organoid engineering strategies support culture growth, proliferation, differentiation maturation been reported. This Primer serves to highlight rationale underlying selection development these materials methods control cellular/tissue niche; therefore, engineered organoid. We discuss key considerations generating robust organoids, those related cell isolation seeding, matrix soluble factor selection, physical cues integration. The general standards data quality, reproducibility deposition within community is outlined. Lastly, we conclude by elaborating limitations organoids different applications, priorities coming years.

Язык: Английский

Процитировано

444

Volumetric Bioprinting of Organoids and Optically Tuned Hydrogels to Build Liver‐Like Metabolic Biofactories DOI Creative Commons
Paulina Núñez Bernal, Manon Bouwmeester, Jorge Madrid‐Wolff

и другие.

Advanced Materials, Год журнала: 2022, Номер 34(15)

Опубликована: Фев. 15, 2022

Organ- and tissue-level biological functions are intimately linked to microscale cell-cell interactions the overarching tissue architecture. Together, biofabrication organoid technologies offer unique potential engineer multi-scale living constructs, with cellular microenvironments formed by stem cell self-assembled structures embedded in customizable bioprinted geometries. This study introduces volumetric bioprinting of complex organoid-laden which capture key human liver. Volumetric via optical tomography shapes gelatin hydrogels into centimeter-scale 3D under 20 s. Optically tuned bioresins enable refractive index matching specific intracellular structures, countering disruptive impact cell-mediated light scattering on printing resolution. layerless, nozzle-free technique poses no harmful mechanical stresses organoids, resulting superior viability morphology preservation post-printing. Bioprinted organoids undergo hepatocytic differentiation showing albumin synthesis, liver-specific enzyme activity, remarkably acquired native-like polarization. Organoids within low stiffness gelatins (<2 kPa) mathematically defined lattices varying degrees pore network tortuosity, cultured perfusion. These act as metabolic biofactories ammonia detoxification can be enhanced architectural profile constructs. technology opens up new possibilities for regenerative medicine personalized drug testing.

Язык: Английский

Процитировано

169

iPSC-based disease modeling and drug discovery in cardinal neurodegenerative disorders DOI Creative Commons
Hideyuki Okano, Satoru Morimoto

Cell stem cell, Год журнала: 2022, Номер 29(2), С. 189 - 208

Опубликована: Фев. 1, 2022

Язык: Английский

Процитировано

120

Human organoids: New strategies and methods for analyzing human development and disease DOI Creative Commons
Nina S. Corsini, Juergen A. Knoblich

Cell, Год журнала: 2022, Номер 185(15), С. 2756 - 2769

Опубликована: Июль 1, 2022

For decades, insight into fundamental principles of human biology and disease has been obtained primarily by experiments in animal models. While this allowed researchers to understand many biological processes great detail, some developmental mechanisms have proven difficult study due inherent species differences. The advent organoid technology more than 10 years ago established laboratory-grown organ tissues as an additional model system recapitulate human-specific aspects biology. use 3D organoids, well other advances single-cell technologies, revealed unprecedented insights mechanisms, especially those that distinguish humans from species. This review highlights novel with a focus on how generated better understanding development disease.

Язык: Английский

Процитировано

95

Chronic hepatitis E: Advancing research and patient care DOI Creative Commons
Zhongren Ma, Robert A. de Man, Nassim Kamar

и другие.

Journal of Hepatology, Год журнала: 2022, Номер 77(4), С. 1109 - 1123

Опубликована: Май 21, 2022

The hepatitis E virus (HEV) was initially thought to exclusively cause acute hepatitis. However, the first diagnosis of chronic in transplant recipients 2008 profoundly changed our understanding this pathogen. We have now begun understand that specific HEV genotypes can infection certain immunocompromised populations. Over past decade, dedicated clinical and experimental research has substantiated knowledge on epidemiology, transmission routes, pathophysiological mechanisms, diagnosis, features treatment infection. Nevertheless, many gaps major challenges remain, particularly regarding translation into disease prevention improvement outcomes. This article aims highlight latest developments management E. More importantly, we attempt identify discuss strategies for further advancing both patient care.

Язык: Английский

Процитировано

82

Progress in multicellular human cardiac organoids for clinical applications DOI Creative Commons
Hyeonyu Kim,

Roger D. Kamm,

Gordana Vunjak‐Novakovic

и другие.

Cell stem cell, Год журнала: 2022, Номер 29(4), С. 503 - 514

Опубликована: Апрель 1, 2022

Язык: Английский

Процитировано

81

Single-cell atlas of human liver development reveals pathways directing hepatic cell fates DOI
Brandon T. Wesley, Alexander Ross, Daniele Muraro

и другие.

Nature Cell Biology, Год журнала: 2022, Номер 24(10), С. 1487 - 1498

Опубликована: Сен. 15, 2022

Язык: Английский

Процитировано

80

Human pluripotent-stem-cell-derived organoids for drug discovery and evaluation DOI Creative Commons
J. Jeya Vandana, Cassandra Manrique, Lauretta A. Lacko

и другие.

Cell stem cell, Год журнала: 2023, Номер 30(5), С. 571 - 591

Опубликована: Май 1, 2023

Human pluripotent stem cells (hPSCs) and three-dimensional organoids have ushered in a new era for disease modeling drug discovery. Over the past decade, significant progress has been deriving functional from hPSCs, which applied to recapitulate phenotypes. In addition, these advancements extended application of hPSCs screening clinical-trial safety evaluations. This review provides an overview achievements challenges using hPSC-derived conduct relevant high-throughput, high-contentscreens evaluation. These studies greatly enhanced our knowledge toolbox precision medicine.

Язык: Английский

Процитировано

61

A platform for efficient establishment and drug-response profiling of high-grade serous ovarian cancer organoids DOI Creative Commons
Wojciech Senkowski, Laura Gall-Mas, Matías Marín Falco

и другие.

Developmental Cell, Год журнала: 2023, Номер 58(12), С. 1106 - 1121.e7

Опубликована: Май 5, 2023

The broad research use of organoids from high-grade serous ovarian cancer (HGSC) has been hampered by low culture success rates and limited availability fresh tumor material. Here, we describe a method for generation long-term expansion HGSC with efficacy markedly improved over previous reports (53% vs. 23%-38%). We established cryopreserved material, demonstrating the feasibility using viably biobanked tissue organoid derivation. Genomic, histologic, single-cell transcriptomic analyses revealed that recapitulated genetic phenotypic features original tumors. Organoid drug responses correlated clinical treatment outcomes, although in conditions-dependent manner only maintained human plasma-like medium (HPLM). Organoids consenting patients are available to community through public biobank genomic data explorable an interactive online tool. Taken together, this resource facilitates application basic translational research.

Язык: Английский

Процитировано

43

Towards a better understanding of diabetes mellitus using organoid models DOI Open Access
Belin Selcen Beydag-Tasöz, Siham Yennek, Anne Grapin‐Botton

и другие.

Nature Reviews Endocrinology, Год журнала: 2023, Номер unknown

Опубликована: Янв. 20, 2023

Язык: Английский

Процитировано

42